IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 1, 2010
(Investigative Ophthalmology and Visual Science. )
© 2009 by The Association for Research in Vision and Ophthalmology, Inc.
doi:10.1167/iovs.09-3539

This Article
Right arrow Full Text (P<P[PDF])
Right arrow All Versions of this Article:
iovs.09-3539v1
51/1/223    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Russ, P. K
Right arrow Articles by Chang, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Russ, P. K
Right arrow Articles by Chang, M. S.

Article

Bves Overexpression in Trabecular Meshwork Cells Inhibits RhoA Signaling

Patricia K Russ 1, Asher I. Kupperman 2, Sai-Han Presley 3, Frederick R Haselton 1, and Min S. Chang 4*

1 Biomedical Engineering, Vanderbilt University, Nashville, Tennessee, United States
2 School of Medicine, Vanderbilt University, Nashville, Tennessee, United States
3 Dept. of Ophthalmology, Vanderbilt University Medical Center, Nashville, Tennessee, United States
4 Biomedical Engineering, Vanderbilt University, Nashville, Tennessee, United States; Dept. of Ophthalmology, Vanderbilt University Medical Center, Nashville, Tennessee, United States

* To whom correspondence should be addressed. E-mail: min.chang{at}vanderbilt.edu.


   Abstract

Purpose: Blood Vessel Epicardial Substance (Bves) is a novel adhesion molecule that regulates tight junction (TJ) formation. TJs also modulate RhoA signaling, which has been implicated in outflow regulation. Since Bves has been reported in multiple ocular tissues, we hypothesize that Bves plays a role in regulation of RhoA signaling in TM cells. Methods: Human TM cell lines NTM-5 and NTM-5 transfected to overexpress Bves (NTM-w) were evaluated for TJ formation, and levels of occludin, cingulin and ZO-1 protein were compared. Assays of TJ function were carried out using diffusion of sodium fluorescein and transcellular electrical resistance (TER). Levels of activated RhoA were measured using FRET probes, and phosphorylation of myosin light chain (MLC-p), a downstream target of RhoA, was assessed by Western blot. Results: Overexpression of Bves led to increased TJ formation in NTM-5 cells. Increased TJ formation was confirmed by increased occludin, cingulin, and ZO-1 protein. Functionally, NTM-w cells showed decreased permeability and increased TER compared to NTM-5 cells, consistent with increased TJ formation. NTM-w cells also exhibited decreased levels of active RhoA and lower levels of MLC-p compared to NTM-5 cells. These findings support a TJ role in RhoA signaling. Conclusions: Increased Bves in TM cells leads to increased TJ formation with decreased RhoA activation and decreased MLC-p. This is the first report of a regulatory pathway upstream of RhoA in TM cells. In TM tissue, RhoA has been implicated in outflow regulation, and thus Bves may be a key regulatory molecule in aqueous outflow.

Key Words: aqueous flow, cell adhesion, cell culture, glaucoma anterior segment, intercellular adhesion molecules, trabecular meshwork







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the Association for Research in Vision and Ophthalmology